Methamphetamine: putting the brakes on speed

Jacob P Gettig1, Sarah E Grady, Izabella Nowosadzka

  • 1Midwestern University Chicago College of Pharmacy, Downers Grove, IL, USA.

Insights

Methamphetamine abuse, once urban, now affects rural areas, with 6.2% of high school seniors trying it. Prevention education is key to combating this dangerous drug.

Area of Science:

  • Public Health
  • Substance Abuse Research
  • Adolescent Health

Background:

  • Illicit methamphetamine use has expanded from urban to rural areas in the US.
  • Despite legislative efforts, methamphetamine abuse remains a significant public health concern.
  • A 2004 survey revealed 6.2% of high school seniors have experimented with methamphetamine.

Purpose of the Study:

  • To highlight the expanding reach of methamphetamine abuse into new demographics.
  • To inform healthcare professionals, particularly nurses, about recognizing methamphetamine abuse symptoms.
  • To emphasize the need for effective prevention strategies for adolescent methamphetamine use.

Main Methods:

  • Literature review on methamphetamine prevalence and impact.
  • Analysis of existing data on methamphetamine abuse trends.
  • Synthesis of information on symptoms, risk factors, and treatment modalities.

Main Results:

  • Methamphetamine abuse is increasingly prevalent in rural Midwest and Southern US regions.
  • Recognizable symptoms include agitation, mood swings, hypertension, and psychosis.
  • Biological, genetic, and environmental factors contribute to adolescent substance abuse.

Conclusions:

  • Nurses play a crucial role in identifying methamphetamine abuse symptoms.
  • Behavioral therapy is the primary treatment for methamphetamine addiction; pharmacologic options are limited.
  • Youth education and prevention programs are the most effective strategy to curb methamphetamine use.

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...